country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-12930

Copy Link Print Information

SPR719

(Synonyms: VXc-486)

4 Cited Publications

Avis client

Based on 4 publication(s) in Google Scholar

SPR719 (VXc-486) is an orally active gyrase B inhibitor, with bactericidal activity. SPR719 potently inhibits multiple agent-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis, with MICs of 0.03 to 0.30 μg/ml and 0.08 to 5.48 μg/ml, respectively. SPR719 is promising for research of lung disease caused by non-tuberculous mycobacteria (NTM).

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

Pureté: 99.39%
CAS No.: 1384984-18-2
Formule: C₂₁H₂₅FN₆O₃
Masse moléculaire:428.46

Stockage:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year

SPR719 Chemical Structure

CAS No.: 1384984-18-2

Size

Prix

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Publications (4)
Solvant et solubilité
- In Vitro
Pureté et documentation
Références
Help & FAQs
Classifications
Bioz

Activité biologique

Description

IC₅₀ & Target

gyrase B^[1]

Voir tous les produits spécifiques à Isoform Topoisomerase :

In Vitro

SPR719 inhibits M. tuberculosis replication in macrophages with a MIC range of 0.125-0.25 μg/mL^[1]^[2].

IC₅₀ (μg/ml) of SPR719 for indicated isolate in macrophages^[1]

Compound	H37Ra	CDC1551
SPR719	0.012	0.115

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

SPR719 (100 mg/kg, oral gavage, twice a day for 4 weeks) combined with pVXc-486 (30 and 100 mg/kg, oral gavage, twice a day for 4 weeks) reduces the mycobacterial burden in a model of chronic tuberculosis infection in mice^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Chronic tuberculosis mouse model^[1]
Dosage:

100 mg/kg
Administration:

oral gavage, twice a day for 4 weeks
Result:

Significantly reduced the median mycobacterial lung burdens in a chronic tuberculosis mouse model.

Chemical Information

CAS No. 1384984-18-2
Appearance Solid
Masse moléculaire 428.46
Formule C₂₁H₂₅FN₆O₃
Color Yellow to brown
SMILES

O=C(NC1=NC2=CC(C3=CN=C(C(C)(O)C)N=C3)=C(F)C([C@@H]4OCCC4)=C2N1)NCC
Synonyms

VXc-486
Livraison

Room temperature in continental US; may vary elsewhere.

Stockage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	2 years
	-20°C	1 year

Publications (4)

All

Sort by:

Journal Impact Factor

Cell

Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. [Abstract]

2021 Aug 19;184(17):4579-4592.e24. PMID: 34297925
ACS Infect Dis

Role of DNA Double-Strand Break Formation in Gyrase Inhibitor-Mediated Killing of Nonreplicating Persistent Mycobacterium tuberculosis in Caseum. [Abstract]

2024 Oct 11;10(10):3631-3639. PMID: 39315541
Antimicrob Agents Chemother

Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection. [Abstract]

2023 Feb 16;67(2):e0145922. PMID: 36688684
Antimicrob Agents Chemother

Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus. [Abstract]

2021 Jul 16;65(8):e0067621. PMID: 34001512

Solvant et solubilité

In Vitro:

DMSO : 20 mg/mL (46.68 mM; ultrasonic and adjust pH to 2 with HCl; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.3339 mL

11.6697 mL

23.3394 mL

5 mM

0.4668 mL

2.3339 mL

4.6679 mL

10 mM

0.2334 mL

1.1670 mL

2.3339 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Pureté et documentation

Select Batch:

Pureté: 99.98%

Assay: 99.98%

ee.: 99.98%

Fiche technique (275 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Instruction de manipulation (2659 KB)

Références

[1]. Locher CP, et al. A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections. Antimicrob Agents Chemother. 2015 Mar;59(3):1455-65. [Content Brief]

[2]. Pidot SJ, et al. In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera. PLoS Negl Trop Dis. 2021 Jul 26;15(7):e0009636. [Content Brief]

[3]. Aragaw WW, et al. In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus. Microbiol Spectr. 2022 Feb 23;10(1):e0132121. [Content Brief]

[4]. Cotroneo N, et al. In vitro activity and in vivo efficacy against non-tuberculous mycobacteria of SPR719, the active moiety of the novel oral benzimidazole prodrug SPR720[J]. bioRxiv, 2022: 2022.12. 08.519697.

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.3339 mL	11.6697 mL	23.3394 mL	58.3485 mL
	5 mM	0.4668 mL	2.3339 mL	4.6679 mL	11.6697 mL
	10 mM	0.2334 mL	1.1670 mL	2.3339 mL	5.8349 mL
	15 mM	0.1556 mL	0.7780 mL	1.5560 mL	3.8899 mL
	20 mM	0.1167 mL	0.5835 mL	1.1670 mL	2.9174 mL
	25 mM	0.0934 mL	0.4668 mL	0.9336 mL	2.3339 mL
	30 mM	0.0778 mL	0.3890 mL	0.7780 mL	1.9450 mL
	40 mM	0.0583 mL	0.2917 mL	0.5835 mL	1.4587 mL

Keywords

SPR719

4 Cited Publications

100 mg Obtenir un devis

Subscribe to the

MedChemExpress

Newsletter

MOQ

Minimum order quantity

100 mg

Obtenir un devis En stock

Other size

Obtenir un devis

Amount: USD 0.00

Activité biologique
- Description
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Publications (4)
Solvant et solubilité
- In Vitro
Pureté et documentation
Références

Nom du produit:
Cat. No.:
Quantité:
MCE Japan Authorized Agent:

Nom du produit:
CAS No.:
Species:
Pureté:
Quantité:

SPR719

MCE Bioactive Compound Library

Publications Citing Use of MedChemExpress (MCE) SPR719

Voir tous les produits spécifiques à Isoform Topoisomerase

Activité biologique

Chemical Information

Publications (4)

Solvant et solubilité

Pureté et documentation

Références

Help & FAQs

Complete Stock Solution Preparation Table

SPR719

MCE Bioactive Compound Library

Publications Citing Use of MedChemExpress (MCE) SPR719

Voir tous les produits spécifiques à Isoform Topoisomerase

Activité biologique

Chemical Information

Publications (4)

Solvant et solubilité

Pureté et documentation

Références

Help & FAQs

Complete Stock Solution Preparation Table

SPR719 Related Classifications

HY-12930 Related Classifications